Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
Phase 2
40
about 2.3 years
18–75
1 site in NY
What this study is about
This trial is testing a new treatment to improve chronic migraine symptoms. The treatment involves an infusion of lidocaine into blood vessels in the skull to numb pain receptors, potentially reducing migraine intensity, frequency, and duration.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Lidocaine (drug)
- 2.Undergo Lidocaine Procedure
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
lidocaine, local anesthetic (Blocks sodium channels to numb tissue locally)
topical (Topical Cream)
Secondary: Adverse events at 24 hours and 3 months post-procedure., Mean change from baseline in the Global Assessment of Migraine Severity (GAMS) at 3 months, Sustained freedom from headache pain >48hrs.
Neurology